¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"zero end expiratory pressure"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀåÀ§Ãà
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
  • bite pressure impression
    ¸Â¹°¸²´©¸§ÀÚ±¹, ±³ÇÕ¾ÐÀλó
  • biting pressure
    ¹°¸²¾Ð, ±³ÇÕ¾Ð
  • bladder pressure
    ¹æ±¤¾Ð
  • blood pressure
    Ç÷¾Ð
  • blood pressure crisis
    Ç÷¾ÐÀ§±â
  • blood pressure cuff
    Ç÷¾ÐÃøÁ¤¶ì
  • blood pressure fluctuation
    Ç÷¾Ðº¯µ¿, Ç÷¾Ð±âº¹
  • blood pressure manometer
    Ç÷¾Ð°è
  • capillary pressure
    ¸ð¼¼Ç÷°ü¾Ð
  • cold pressure test
    ÇÑ·©¾Ð¹Ú°Ë»ç
  • continuous positive airway pressure
    Áö¼Ó±âµµ¾ç¾Ð
  • continuous positive pressure breathing
    Áö¼Ó¼º¾ç¾ÐÈ£Èí(¹ý)
  • cricoid pressure
    ¹ÝÁö¿¬°ñ´©¸£±â, À±»ó¿¬°ñ´©¸£±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • automatic intermittent positive pressure
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • automatic intermittent positive pressure respirator
    ÀÚµ¿°£Çæ¾ç¾ÐÈ£Èí±â
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀ§Ãà
  • pressure alopecia
    ¾Ð·ÂÅ»¸ðÁõ
  • pressure atrophy
    ¾Ð¹ÚÀ§Ãà
  • pressure autoregulation
    ¾Ð·ÂÀÚµ¿Á¶Àý
  • pressure breathing assister
    °¡¾ÐÈ£Èíº¸Á¶±â
  • back-pressure effect
    ÈĹæ¾Ð·ÂÈ¿°ú
  • barometric pressure
    ±â¾Ð
  • basal blood pressure
    ±âÀúÇ÷¾Ð
  • bite pressure
    ±³ÇÕ¾Ð, ¸Â¹°¸²¾Ð
  • bite pressure impression
    ¸Â¹°¸²´©¸§ÀÚ±¹, ±³ÇÕ¾ÐÀλó
  • blood pressure
    Ç÷¾Ð
  • blood pressure crisis
    Ç÷¾ÐÀ§±â
  • blood pressure cuff
    Ç÷¾ÐÃøÁ¤¶ì
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • inner pressure
    ³»¾Ð(Ò®äâ).
  • inspiratory pressure
    Èí±â¾Ð.
  • inspiratory triggering pressure
    Èí±âÀ¯¹ß¾Ð.
  • pleural pressure
    È丷°­¾Ð.
  • portal blood pressure
    ¹®¸Æ¾Ð(Ú¦Øæäâ).
  • positive airway pressure
    ±âµµ¾ç¾Ð(ѨԳ åÕäâ).
  • positive negative pressure respiration
    ¾çÀ½¾ÐÈ£Èí(¹ý)(åÕëääâû¼ýåÛö), ¾ç À½¾Ðȯ±â(¹ý)(¡­üµÑ¨Ûö).
  • positive negative pressure ventilation
    ¾çÀ½¾ÐÈ£Èí(¹ý), ¾çÀ½¾Ðȯ±â(¹ý).
  • positive pressure
    ¾ç¾Ð(åÕäâ), Á¤¾Ð(ïáäâ).
  • positive pressure breathing
    ¾ç¾ÐÈ£Èí(¹ý).
  • positive pressure ventilation
    ¾ç¾Ðȯ±â(¹ý).
  • pressure
    ¾Ð(·Â)
  • pressure
    ¾Ð·Â (äâÕô)
  • pressure abrasion
    ¾Ð¹Ú¼º Ç¥ÇǹÚÅ»(äâÚÞàõøúù«ÚÎ÷­).
  • pressure accumulator
    Ãà¾Ð±â(õëäâÐï).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • end artery
    Á¾µ¿¸Æ(ðûÔÑØæ).
  • end bulb of Krause
  • end dilution value =EDV
    ü¿ÜÈñ¼®Ä¡(ô÷èâýüà·ö·).
  • end feet
  • end group
    ¸»´Ü±â.
  • end organ
    Á¾¸»±â(°ü).
  • end path
    Á¾·Î(ðûÖØ).
  • end piece
    ³¡ºÎºÐ
  • end product
    ÃÖÁ¾»ê¹°.»ýÈ­Á¾»ê¹°.
  • end stage renal disease, ESRD
    ¸»±â½ÅÁúȯ
  • end ureterostomy
    ´Ü´Ü ¿ä°ü·çÁ¶¼º¼ú?
  • end-cutaneous ureterostomy
    ´Ü´Ü ÇǺΠ¿ä°ü·çÁ¶¼º¼ú?
  • end-diastolic volume
    È®Àå±â¸»¿ëÀû(¡­éÄîÝ)
  • end-expiration
    È£Èí °áÇÙÈ£±â¸»±â.
  • end-organ deafness
    Á¾¸»±â°ü(¼º) ³­Ã»
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
ESP early systolic paradox; echo spacing; effective sensory projection; effective systolic pressure; end...
CEEA curved end-to-end anastomosis [stapler]
EDCS end-diastolic chamber stiffness; end-diastolic circumferential stress
EDL end-diastolic length; end-diastolic load; estimated date of labor; extensor digitorum longus
EEA electroencephalic audiometry; end-to-end anastomosis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
LVEDP LV end diastolic pressure
LVEDP Left Ventricular End Diastolic Pressure
ESP end systolic pressure
RVEDP right ventricular end-diastolic pressure
PCO2 pressure , carbon dioxide pressure
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • continuous-infusion pressure-monitored
    ¿¬¼Ó ÁÖÀÔ¾Ð ÃøÁ¤
  • deep pressure
    ½ÉºÎ ¾Ð·Â
  • Donders' pressure
    µ·´õ ¾Ð
    ½ÃüÀÇ ÈäºÎ¸¦ Àý°³ÇÏ°í ±â°ü À§¿¡ ¾Ð·Â°è¸¦ ³õÀ¸¸é ¾Ð·ÂÀÌ Áõ°¡µÇ´Âµ¥ ÀÌ´Â Æó°¡ ÇãÅ»À» ÀÏÀ¸Å°±â ¶§¹®ÀÌ´Ù.
  • enddiastolic pressure
    È®Àå ¸»±â ¾Ð
  • endocardial pressure
    ½É³»¾Ð
    ½ÉÀå³»ÀÇ Ç÷¾Ð.
  • filling pressure
    ÃæÀü ¾Ð·Â, ÃæÀü ¾Ð
  • filtrating pressure
    ¿©°ú¾Ð, ¿©°ú ¾Ð·Â
  • free portal pressure
    ÀÚÀ¯ ¹®¸Æ¾Ð
  • hydrostatic pressure
    Á¤¼ö¾Ð
    ¹°ÀÌ ¾î¶² ³ôÀÌ¿¡¼­µçÁö Á¡¼ö »óÅ¿¡ ÀÖÀ» ¶§ ¹°ÀÇ Á߷¿¡ ÀÇÇØ »ý±â´Â ¾Ð·Â. È帣Áö ¾Ê°í ±«¾î ÀÖ´Â ¹° ¼Ó¿¡ ÀÛ¿ëÇÏ´Â ¾Ð·Â.
  • intermittent positive pressure breathing
    °£ÇæÀû Á¤¾Ð È£Èí¹ý
    ¼øÈ¯ÆÇÀ¸·ÎºÎÅÍÀÇ ÀÏÁ¤ ¾Ð·ÂÇÏ¿¡¼­ ÈíÀÔÇÏ´Â µ¿¾È¿¡ Æó°¡ ÀÚµ¿ÀûÀ¸·Î ÆØÃ¢ÇÏ´Â °Í.
  • intra-abdominal pressure
    º¹°­ ³»¾Ð
    º¹°­³» ³»Àå°£ÀÇ ¾Ð·Â.
  • intracranial pressure
    µÎ°³³» ¾Ð
    µÎ°³°ñ°ú ³ú »çÀÌÀÇ °£°Ý¿¡ ÀÖ´Â ¾Ð·Â. ¿¹ÄÁ´ë ÁöÁÖ¸·ÇÏ ¾×ÀÇ ¾Ð·Â.
  • intrapulmonary pressure
    Æó ³»¾Ð
  • intrathecal pressure
    Ãʳ»¾Ð
    ƯÈ÷ ÁöÁÖ¸· ³»ÀÇ ³ú ô¼ö ¾× ¾Ð·Â.
  • intraventricular pressure
    ½É½Ç ³»¾Ð
    ÇÑ °³ÀÇ ½É½Ç ³»¾Ð. ½É½Ç ³»ÀÇ ¾Ð·Â.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
end plate <anatomy, physiology> The area of sarcolemma immediately below the synaptic region of the motor neuron in a neuromuscular junction. most often refers to the end of a nerve fibre against a skeletal muscle fibre, to which it transmits nerve signals.
(18 Nov 1997)
end plate potential <physiology> Depolarisation of the sarcolemma as a result of acetylcholine release from the motoneuron causing an influx of sodium ions. The endplate potential is the sum of quantal miniature endplate potentials. Development of the end plate potential is blocked by curare.
(18 Nov 1997)
end point <chemistry> It is the completion point during a titration reaction where there are equal amounts of titrant and whatever is being titrated. It is usually evident by the first perceptible alteration of the colour of an added indicator.
<immunology> It is the most dilute an antibody or antiserum solution can be while still detectably reacting with the antigen.
<statistics> A category of data used to compare the outcome in different arms of a clinical trial. Common endpoints are severe toxicity, disease progression or fall in such surrogate markers as CD4 count, but sometimes death is used as an endpoint.
(08 Mar 2000)
end-point measurement Analytical measurement at the end of a chemical reaction, as opposed to making the measurement while the reaction proceeds.
(05 Mar 2000)
end-point nystagmus A jerky, physiologic nystagmus occurring in a normal individual when attempts are made to fixate a point at the limits of the field of fixation.
Synonym: deviational nystagmus.
(05 Mar 2000)
end product <biochemistry> The final product of after a series of reactions with enzymes in a biochemical metabolic pathway has taken place.
(09 Oct 1997)
end product inhibition <biochemistry, physiology> The process of the end product of a particular metabolic reaction inhibiting an allosteric enzyme involved in that reaction as the reaction starts again, thus breaking the reaction cycle.
(09 Oct 1997)
end product repression Catabolite repression in which the catabolite is an end product of a particular pathway.
(05 Mar 2000)
end stage The late, fully developed phase of a disease; e.g., in end-stage renal disease, a shrunken and scarred kidney that may result from a variety of chronic diseases that have become indistinguishable in their effect on the kidney.
(05 Mar 2000)
end-stage renal disease <nephrology> A patient with inadequate renal function to support life. Individuals with end-stage disease must rely in kidney dialysis or peritoneal dialysis to survive. End-stage renal disease may be caused by a number of problems including diabetes, sickle cell disease, hypertension and congenital renal disease (polycystic kidney disease).
(27 Sep 1997)
end-systolic volume The amount of blood in the ventricle at the end of the cardiac ejection period and immediately preceding the beginning of ventricular relaxation; a measurement of the adequacy of cardiac emptying, related to systolic function.
(05 Mar 2000)
end-tidal at the end of a normal expiration.
(05 Mar 2000)
end-tidal sample A sample of the last gas expired in a normal expiration, ideally consisting only of alveolar gas.
(05 Mar 2000)
Krause's end bulbs Nerve terminals in skin, mouth, conjunctiva, and other parts, consisting of a laminated capsule of connective tissue enclosing the terminal, branched, convoluted ending of an afferent nerve fibre; generally believed to be sensitive to cold.
Synonym: corpuscula bulboidea, bulboid corpuscles.
(05 Mar 2000)
flush end <molecular biology> The ends of a blunt-end DNA molecule, where both strands in the double-stranded DNA molecule are even with each other rather than one strand being longer than the other.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • end matter
    (ÀÎ)Ã¥ÀÇ ºÎ·Ï(ÁÖ¼®,Âü°í ¹®Çå ¸ñ·Ï,»öÀÎ µî)
  • end organ
    (»ý¸®)(½Å°æÀÇ)Á¾¸» ±â°ü;´Ü¸»±â
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • end product
    ¿¬¼Ó º¯È­ÀÇ ÃÖÁ¾°á°ú;ÃÖÁ¾ »ý¼º¹°
  • end rhyme
    (¿î)°¢¿î
  • end run
    ¿£µå·±(°øÀ» °¡Áø ¼±¼ö°¡ ¾Æ±º ¹æ¾îÁøÀÇ Ãø¸éÀ» µ¹¾Æ ÈĹæÀ¸·Î ³ª°¡´Â Ç÷¹ÀÌ)±³¹¦ÇÑ È¸ÇÇ
  • end stop
    ¹®¹Ì ±âÈ£
  • end table
    (¼ÒÆÄ,ÀÇÀÚ °ç¿¡ ³õ´Â)ÀÛÀº Å×À̺í
  • end use
    ÃÖÁ¾ ¿ëµµ
  • end user
    ÃÖÁ¾ ¼ö¿äÀÚ;½Ç¼ö¿äÀÚ
  • end ways
    ³¡À» À§·ÎÇϰí;¼¼·Î
  • end zone
    ¿£µå Á¸(°ñ¶óÀΰú ¿£µå¶óÀÎ »çÀÌÀÇ ±¸¿ª)
  • end-
    (¿¬°áÇü)(³»ºÎ,Èí¼ö)ÀÇ ¶æ
  • fag end
    µµ·Á³½ ³¡ Á¶°¢;¸»´Ü;³²Àº Çã¼·¾²·¹±â;´ã¹è;Åä²ø;»õ³¢ÀÇ ²¿Áö ¾ÊÀº ²ôÆ®·¯¹Ì
  • front end
    ÇÁ·ÐÆ® ¿£µå(ÁõÆø,Áß°£ Á֯ļö º¯È¯ºÎ)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 5
ÅëÇÕ°Ë»ö ¿Ï·á